302 related articles for article (PubMed ID: 29566767)
1. Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.
Suzuki K; Yoshida K; Ueha T; Kaneshiro K; Nakai A; Hashimoto N; Uchida K; Hashimoto T; Kawasaki Y; Shibanuma N; Nakagawa N; Sakai Y; Hashiramoto A
Arthritis Res Ther; 2018 Mar; 20(1):55. PubMed ID: 29566767
[TBL] [Abstract][Full Text] [Related]
2. TNF-α modulates expression of the circadian clock gene Per2 in rheumatoid synovial cells.
Yoshida K; Hashiramoto A; Okano T; Yamane T; Shibanuma N; Shiozawa S
Scand J Rheumatol; 2013; 42(4):276-80. PubMed ID: 23496259
[TBL] [Abstract][Full Text] [Related]
3. PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.
Ritchie A; Gutierrez O; Fernandez-Luna JL
Cell Death Differ; 2009 Jun; 16(6):838-46. PubMed ID: 19219069
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.
Li YB; Xu P; Xu K; Cai YS; Sun MY; Yang L; Sun J; Lu SM
Mol Cell Biochem; 2016 Sep; 420(1-2):161-70. PubMed ID: 27522665
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
[TBL] [Abstract][Full Text] [Related]
6. Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis.
Nakajima A; Hakoda M; Yamanaka H; Kamatani N; Kashiwazaki S
Ann Rheum Dis; 1996 Apr; 55(4):237-42. PubMed ID: 8733440
[TBL] [Abstract][Full Text] [Related]
7. Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1.
Xu K; Cai YS; Lu SM; Li XL; Liu L; Li Z; Liu H; Xu P
Arthritis Res Ther; 2015 Dec; 17():374. PubMed ID: 26702616
[TBL] [Abstract][Full Text] [Related]
8. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
10. TNF-α induces expression of the circadian clock gene Bmal1 via dual calcium-dependent pathways in rheumatoid synovial cells.
Yoshida K; Nakai A; Kaneshiro K; Hashimoto N; Suzuki K; Uchida K; Hashimoto T; Kawasaki Y; Tateishi K; Nakagawa N; Shibanuma N; Sakai Y; Hashiramoto A
Biochem Biophys Res Commun; 2018 Jan; 495(2):1675-1680. PubMed ID: 29217191
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
[TBL] [Abstract][Full Text] [Related]
12. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
13. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
Stamp LK; Hazlett J; Highton J; Hessian PA
J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
[TBL] [Abstract][Full Text] [Related]
15. Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF.
Haas S; Straub RH
Arthritis Res Ther; 2012 May; 14(3):R122. PubMed ID: 22621205
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.
Spurlock CF; Gass HM; Bryant CJ; Wells BC; Olsen NJ; Aune TM
Rheumatology (Oxford); 2015 Jan; 54(1):178-87. PubMed ID: 25118313
[TBL] [Abstract][Full Text] [Related]
17. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
18. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the HOX4C gene by basic fibroblast growth factor on rheumatoid synovial fibroblasts.
Xue C; Hasunuma T; Asahara H; Yin W; Maeda T; Fujisawa K; Dong Y; Sumida T; Nishioka K
Arthritis Rheum; 1997 Sep; 40(9):1628-35. PubMed ID: 9324017
[TBL] [Abstract][Full Text] [Related]
20. Synoviocyte apoptosis may differentiate responder and non-responder patients to methotrexate treatment in rheumatoid arthritis.
Lee SY; Park SH; Lee SW; Lee SH; Son MK; Choi YH; Chung WT; Yoo YH
Arch Pharm Res; 2014 Oct; 37(10):1286-94. PubMed ID: 24988987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
